Elevated serum KL-6 concentrations in patients with diabetes mellitus

Journal of Diabetes and its Complications

Volumn 16, Issue 5, 2002, Pages 352-358

  Takahashi, Toru ^a,b   Takamura, Kei ^a   Sakaue, Sinji ^a   Ishii, Jun ^c   Yokouchi, Hiroshi ^a   Nasuhara, Yasuyuki ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Hokkaido Central Hospital for Social Health Insurance   (Japan)

Author keywords

CA19 9; Diabetic nephropathy; HbA1c; Henle's loop; Immunohistochemistry; Renal tubules

Indexed keywords

ANTIGEN; GLUCOSE; GLYCOPROTEIN; HEMOGLOBIN A1C; INSULIN; KREBS VON DEN LUNGEN 6 PROTEIN; MONOCLONAL ANTIBODY; ORAL ANTIDIABETIC AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DIET; EPITHELIUM CELL; EXERCISE; FEMALE; GLOMERULOSCLEROSIS; GLOMERULUS; GLUCOSE BLOOD LEVEL; HENLE LOOP; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY; KIDNEY TUBULE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN URINE LEVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; BIOLOGICAL MARKERS; DIABETES MELLITUS; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PEPTIDE FRAGMENTS; PROCOLLAGEN; REFERENCE VALUES;

EID: 0036740922     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(01)00220-3     Document Type: Article

References (29)

1. Aoki Y., Yanagisawa Y., Ohfusa H., Kawa S., Oguchi H., Furuta S. Elevation of serum CA 19-9 in parallel with HbA1c in a diabetic female with the Lewis (a+,b-) blood group. Diabetes Research and Clinical Practice. 13:1991;77-81.
2. Banfi G., Ardemagni A., Bravi S., Pacchioni M., Bonini P. Are diabetic metabolic compensation and CA 19.9 really correlated? International Journal of Biological Markers. 11:1996;207-210.
3. Bjorn S.F., Bangstad H.J., Hanssen K.F., Nyberg G., Walker J.D., Viberti G.C., Osterby R. Glomerular epithelial foot processes and filtration slits in IDDM patients. Diabetologia. 38:1995;1197-1204.
4. Ellis E.N., Steffes M.W., Chavers B., Mauer S.M. Observations of glomerular epithelial cell structure in patients with type I diabetes mellitus. Kidney International. 32:1987;736-741.
5. Hermans C., Bernard A. Lung epithelium-specific proteins. American Journal of Respiratory Critical Care Medicine. 159:1999;646-678.
6. Johnson M.A., Kwan S., Snell N.J., Nunn A.J., Darbyshire J.H., Turner-Warwick M. Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose of prednisolone in combination in cryptogenic fibrosing alveolitis. Thorax. 44:1989;280-288.
7. King G.L., Banskota N.K. Mechanisms of diabetic microvascular complications. Weir C.R., Kahn G.C. Joslin's diabetes mellitus. 1994;631-647 Williams & Wilkins, Baltimore.
8. King T.E. Jr. Idiopathic pulmonary fibrosis. Schwarz M.I., King T.E. Jr. Interstitial lung disease. 1998;597-644 Decker, Ontario.
9. Kobayashi J., Kitamura S. KL-6: a serum marker for interstitial pneumonia. Chest. 108:1995;311-315.
10. Kobasyashi J., Kitamura S. Serum KL-6 for the estimation of active pneumonitis in pulmonary sarcoidosis. Chest. 109:1996;1276-1282.
11. Kohno N., Akiyama M., Kyoizumi S., Hakoda M., Kobuke K., Yamakido M. Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma. Japan Journal of Clinical Oncology. 18:1988;203-216.
12. Kohno N., Awaya Y., Oyama T., Yamakido M., Akiyama M., Inoue Y., Yokoyama A., Hamada H., Fujioka S., Hiwada K. KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease. American Review of Respiratory Disease. 148:1993;637-642.
13. Kohno N., Kyoizumi S., Awaya Y., Fukuhara H., Yamakido M., Akiyama M. New serum indicator of interstitial pneumonitis activity. Chest. 96:1989;68-73.
14. Committee of Japan Diabetes Society for the Diagnostic Criteria of Diabetes Mellitus, Kuzuya T., Nakagawa S., Satoh J., Kanazawa Y., Iwamoto Y., Kobayashi M., Nanjo K., Sasaki A., Seino Y., Ito C., Shima K., Nonaka K., Kadowaki T. Report of the Committee of Japan Diabetic Society on the Classification and Diagnostic Criteria of Diabetes Mellitus. Journal of Japan Diabetic Society. 42:1999;385-404.
15. Magnani J.L., Brockhaus M., Smith D.F., Ginsburg V., Blaszczyk M., Mitchell K.F., Steplewski Z., Koprowski H. A monosialoganglioside is a monoclonal antibody-defined antigen of colon carcinoma. Science. 212:1981;55-56.
16. Magnani J.L., Nilsson B., Brockaus M., Zopf D., Steplewski Z., Koprowski H., Ginsburg V. A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II. Journal of Biological Chemistry. 257:1982;14365-14369.
17. Magnani J.L., Steplewski Z., Koprowski H., Ginsburg V. Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin. Cancer Research. 43:1983;5489-5492.
18. Nakamura N., Aoji O., Yoshikawa T., Mori K., Kajiyama S., Kitagawa Y., Kanasuna T., Kondo M. Elevated serum CA 19-9 levels in poorly controlled diabetic patients. Japanese Journal of Medicine. 25:1986;278-280.
19. Ortiz A., Ziyadeh F.N., Neilson E.G. Expression of apoptosis-regulatory genes in renal proximal tubular epithelial cells exposed to high ambient glucose and in diabetic kidneys. Journal of Investigative Medicine. 45:1997;50-56.
20. Petit J.M., Vaillant G., Olsson N.O., Guignier F., Collignon S., Verges B., Brun J.M. Elevated serum CA 19-9 levels in poorly controlled diabetic patients - relationship with Lewis blood group. Gastroenterologie Clinique et Biologique. 18:1994;17-20.
21. Shimojo N., Naka K., Nakajima C., Ishizaki T., Okuda K., Murai J., Yamamoto M. The effect of non-insulin-dependent diabetes on serum concentrations of tumor-associated carbohydrate antigens of CA19-9, CA50, and sialyl SSEA-1 in association with the Lewis blood phenotype. Clinica Chimica Acta. 190:1990;283-290.
22. Takahashi T., Munakata M., Ohtsuka Y., Satoh-Kamachi A., Sato R., Homma Y., Kawakami Y. Serum KL-6 concentrations in dairy farmers. Chest. 118:2000;445-450.
23. Takahashi T., Munakata M., Suzuki I., Kawakami Y. Serum and bronchoalveolar fluid KL-6 levels in patients with pulmonary alveolar proteinosis. American Journal of Respiratory Critical Care Medicine. 158:1998;1294-1298.
24. Unger R.H., Foster D.W. Diabetes mellitus. Wilson J.D., Foster D.W., Kronenberg H.M., Larsen P.R. Williams textbook of endocrinology. 1998;973-1059 W.B. Saunders, Philadelphia.
25. Viberti G.C., Mackintosh D., Keen H. Determinants of the penetration of proteins through the glomerular barrier in insulin-dependent diabetes mellitus. Diabetes. 32(Suppl. 2):1983;92-95.
26. Vracko R., Thorning D., Huang T.W. Basal lamina of alveolar epithelium and capillaries: quantitative changes with aging and in diabetes mellitus. American Review of Respiratory Disease. 120:1979;973-983.
27. Wiseman M.J., Viberti G.C., Keen H. Threshold effect of plasma glucose in the glomerular hyperfiltration of diabetes. Nephron. 38:1984;257-260.
28. Yokoyama A., Kohno N., Kondo K., Ueda S., Hirasawa Y., Watanabe K., Takada Y., Hiwada K. Comparative evaluation of sialylated carbohydrate antigens, KL-6, CA 19-9 and SLX as serum markers for interstitial pneumonia. Respirology. 3:1998;199-202.
29. Yoshioka K. Elevation and fluctuation of serum CA 19-9 and SPAN-1 levels after administration of sulfonylurea in diabetic with Lewis (a-,b-) blood phenotype. Diabetes Care. 18:1995;1397-1399.